Company
United StatesPublic company, NYSE: RDYDr. Reddy's Laboratories, Inc. (NYSE: RDY), Princeton, NJ – FDA Inspections
Inspection records and compliance data for Dr. Reddy's Laboratories, Inc. in Princeton, New Jersey. 5 FDA inspections on record, last inspected August 21, 2025. Publicly traded as NYSE: RDY.
Company Profile
This profile covers Dr. Reddy's Laboratories, Inc. based in Princeton, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 2
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected May 16, 2011. Last inspected August 21, 2025.
Most cited issue areas
- Failure to comply with REMS Communication Plan1 inspection
- Failure to comply with REMS Medication Guide1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 21, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1280984 |
| May 26, 2022 | VAI | Human Drugs · Bioresearch Monitoring | 1170460 |
| February 7, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1119494 |
| December 16, 2013 | NAI | Human Drugs · Bioresearch Monitoring | 858994 |
| May 16, 2011 | VAI | Human Drugs · Drug Quality Assurance | 725605 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Dr. Reddy's Laboratories, Inc.
Stock ticker
RDY
Exchange
NYSE
Share price
$14.73
Market cap
$12.3B
Price as of
November 13, 2026
FEI Number
3003989912
Address
107 College Rd E, Princeton, New Jersey 08540, United States
Country
United States
ID: ec3847d0-42b8-478b-bb7e-5e986389f184